AI assistant
Sending…
INVO Fertility, Inc. — Director's Dealing 2020
Dec 1, 2020
35465_dirs_2020-12-01_f3726824-b3fc-4d0a-922d-997862ea5bee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INVO Bioscience, Inc. (INVO)
CIK: 0001417926
Period of Report: 2020-11-27
Reporting Person: Szot Matthew K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-27 | Common Stock | A | 2339 | — | Acquired | 2339 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-27 | Stock Option | $3.1924 | A | 2339 | Acquired | 2025-11-27 | Common Stock (2339) | Direct |
More from INVO Fertility, Inc.
Regulatory Filings
2026
Jun 2
Annual Report
2026
Jun 2
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
Feb 24
Major Shareholding Notification
2026
Feb 17
Capital/Financing Update
2026
Feb 12
Regulatory Filings
2026
Feb 6
Capital/Financing Update
2026
Feb 2
Capital/Financing Update
2026
Jan 30
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 26